Instruction to Authors
Submission of Manuscripts
All manuscripts must be submitted on-line / email through the website www.innovativepublication.com or Email Id: editor@innovativepublication.com, rakesh.its@gmail.com
SCOPE
Innovative Publication all journals are Quarterly Journals with National and International circulation. It published original communications of Medical and Dental Science that advances or illuminates medical science or that educates the journal readers. It is quarterly issue in four issue per year.
Manuscripts should be presented in as concise form as possible, typewritten neatly. Pages should be numbered consecutively and the contents arranged in the following order:
TITLE
Title of the article should be short, continuous (broken or hyphenated titles are not acceptable) and yet sufficiently descriptive and informative so as to be useful in indexing and information retrieval.
Title page should include name(s) of author(s) with departmental affiliations, complete postal addresses with e-mails.
Abstract
All manuscripts should (except reviews) have a structured abstract (of about 250 words) with subheadings of Background & objectives, Methods, Results, and Interpretation & conclusions. Abstract should be brief and indicate the scope and significant results of the paper. It should only highlight the principal findings and conclusions so that it can be used by abstracting services without modification. Conclusions and recommendations not found in the text of the articles should not be inserted in the Abstract.
Introduction
Introduction should be brief and state precisely the scope of the paper. Review of the literature should be restricted to reasons for undertaking the present study and provide only the most essential background.
Materials and Methods
The nomenclature, the source of material and equipment used, with the manufacturer's details in parenthesis, should be clearly mentioned. The procedures adopted should be explicitly stated to enable other workers to reproduce the results, if necessary. New methods may be described in sufficient detail indicating their limitations. Established methods can be just mentioned with authentic references and significant deviations, if any given, with reasons for adopting them. While reporting experiments on human subjects. it should be clearly mentioned that procedures followed are in accordance with the ethical standards laid down by the national bodies or organizations of the particular country. For example, for research carried out in India on human subjects, Ethical guidelines for Medical and Dental research on human participants should be adhered to. Similarly, for experiments on laboratory guidelines Use of scientific research.
Discussion
The discussion should deal with the interpretation of results without repeating information already presented under Results. It should relate new findings to the known ones and include logical deductions. It should also mention any weaknesses/limitations/lacunae of the study.
The conclusions can be linked with the goals of the study but unqualified statements and conclusions not completely supported by the data should be avoided. Claiming of priority on work that is ongoing should also be avoided. All hypotheses should, if warranted, clearly be identified as such; recommendations may be included as part of the Discussion, only when considered absolutely necessary and relevant.
Acknowledgment
Acknowledgment should be brief and made for specific scientific/technical assistance and financial support only and not for providing routine departmental facilities and encouragement or for help in the preparation of the manuscripts (including typing or secretarial assistance).
Results
Only such data as are essential for understanding the discussion and main conclusions emerging from the study should be included. The data should be arranged in unified and coherent sequence so that the report develops clearly and logically. Data presented in Tables and Figures should not be repeated in the text. Only important observations need to be emphasized or summarized. The same data should not be presented both in tabular and graphic forms. Interpretation of the data should be taken up only under the Discussion and not under Results.
References
The total number of References should normally be restricted to a maximum of 30.
References to literature cited should be numbered consecutively and placed at the end of the manuscript. In the text they should be indicated above the line (superior). As far as possible mentioning names of author(s) under references should be avoided in text.
Abbreviations
Only standard abbreviations are to be used. The abbreviations should conform to the International System of Units, throughout the text, Tables and Figures. Generic names of the drugs should be used. If proprietary brands are used in research brand name, name of manufacturer and country should be given in parentheses after the generic name at the first place of use.
Review Articles:
The review articles are strictly by invitation from the Editor. It is expected that these articles would be written by individuals who have done substantial work on the subject or are considered experts in the field and are solicited by the editorial board. A short summary of the work done by the contributor(s) in the field of review should accompany the manuscript.
Authors' Contributions
All authors are encouraged to specify their individual contributions at the bottom of the title page or on a separate page. The Innovative Publication will not publish an item unless it has the signatures of all the authors. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is also not sufficient for authorship. Any part of an article critical to its main conclusions must be the responsibility of at least one author.
Conflicts of Interest
A conflict of interest exists if authors or their institutions have financial or personal relationships with other people or organizations that could inappropriately influence (bias) their actions. A conflict can be actual or potential, and full disclosure to the Editor is absolute requirement. All submissions must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest.All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. If there are no conflicts of interest, authors should state be so.
TABLES AND FIGURES
No repetition of data in tables and graphs and in text
Actual numbers from which graphs drawn, provided
Figures necessary and of good quality (colour)
Table and figure numbers in Arabic letters (not Roman)
Labels pasted on back of the photographs (no names written)
Figure legends provided (not more than 40 words)
Patients' privacy maintained (if not permission taken)
Credit note for borrowed figures/tables provided
Write the full term for each abbreviation used in the table as a footnote
IMAGES
Submit good quality color images. Each image should be less than 4 MB in size. Size of the image can be reduced by decreasing the actual height and width of the images (keep up to 1800 x 1200 pixels or 5-6 inches). Images can be submitted as jpeg files. Do not zip the files. Legends for the figures/images should be included at the end of the article file.
This file should provide
The type of manuscript (original article, review article, short communication, Letter to editor, Editorial, etc.) title of the manuscript, running title, names of all authors/ contributors (with their highest academic degrees, designation and affiliations) and name(s) of department(s) and/ or institution(s) to which the work should be credited, . All information which can reveal your identity should be here. Use text/rtf/doc files only.
The total number of pages, total number of photographs and word counts separately for abstract and for the text (excluding the references, tables and abstract), word counts for introduction + discussion in case of an original article;
Source(s) of support in the form of grants, equipment, drugs, or all of these;
Acknowledgement, if any should specify any technical, financial or material support. This should be included in the title page of the manuscript and not in the main article file.
If the manuscript was presented as part at a meeting, the organization, place, and exact date on which it was read. A full statement to the editor about all submissions and previous reports that might be regarded as redundant publication of the same or very similar work. Any such work should be referred to specifically, and referenced in the new paper. Copies of such material should be included with the submitted paper, to help the editor decide how to handle the matter.
Undertaking by Authors
We, the undersigned, give an undertaking to the following effect with regard to our article entitled submitted for publishing with Innovative Publication.
I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
I/We hereby acknowledge Innovative Publication conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) | Signature of Authors |
1. ___________________________ | ______________________________ |
2. ___________________________ | ______________________________ |
3. ____________________________ | ______________________________ |
4. ____________________________ | ______________________________ |
5. ____________________________ | ______________________________ |
6. ____________________________ | ______________________________ |
IMPORTANT
All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/country and whose whereabouts are not known, the senior author may sign on his/her behalf taking the responsibility.
No addition/deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
If the authorship is contested at any stage, the article will be either returned or will not be processed for publication till the issue is solved.
COPYRIGHT TRANSFER AGREEMENT
Innovative Publication all Journals published quarterly at "Innovative Publication office, H -2 / 94, Bengali Colony, Mahaveer Enclave, Part - 1, New Delhi - 110045, India". Innovative Publication and Authors hereby agree as follows: In consideration of Innovative Publication reviewing and editing the following described work for first publication on an exclusive basis:
Title of manuscript:
___________________________________________________________________________________________________________________________________________
The undersigned author(s) hereby assigns, conveys, and otherwise transfers all rights, title, interest, and copyright ownership of said work for publication. Work includes the material submitted for publication and any other related material submitted at Innovative Publication. In the event that Innovative Publication does not publish said work, the author(s) will be so notified and all rights assigned hereunder will revert to the author(s).
The assignment of rights to Innovative Publication includes but is not expressly limited to rights to edit, publish, reproduce, distribute copies, include in indexes or search databases in print, electronic, or other media, whether or not in use at the time of execution of this agreement, and claim copyright in said work throughout the world for the full duration of the copyright and any renewals or extensions thereof.
All accepted works become the property of Innovative Publication and may not be published elsewhere without prior written permission from Innovative Publication. The author(s) hereby represents and warrants that they are sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, that the work is original, and does not infringe upon any copyright, propriety, or personal right of any third party, and that no part of it nor any work based on substantially similar data has been submitted to another publication.
Authors' Names (in sequence) | Signature of Authors |
1. ___________________________ | ______________________________ |
2. ___________________________ | ______________________________ |
3. ____________________________ | ______________________________ |
4. ____________________________ | ______________________________ |
5. ____________________________ | ______________________________ |
6. ____________________________ | ______________________________ |
Plagiarism and Copyright Violations
Plagiarism is defined as the wrongful appropriation, close imitation, or purloining and publication, of another author's language, thoughts, ideas, or expressions, and the representation of them as one's own original work. The journal uses software such as:
Such software ensures that plagiarism-free content only is accepted for publication. Authors should ensure that information provided by them is plagiarism-free, with appropriate citations and references wherever another author's information is used. It should also be noted that providing citations does not justify the mass copying of information to which others own copyright.
Important Information
The embodied thought contents and the opinions expressed in Journal are those of the authors/contributors, and, do not necessarily reflect the views of the members of the Editorial board or the Publication Management Team of the Journal or the Institution to which the authors are affiliated. Journal has full right to accept or reject a manuscript for consideration of publication in it. The decision taken by the Editorial board/Publication Management Team of Journal is final in all respects, and no further communication/clarification/solicitation from authors is expected/entertained.
Journal attempts to clear the manuscripts submitted to it within 1-3 months time-line, but cannot guarantee on further delays. It may cause owing to a number of reasons including the subject specialty of thought contents embodied in it/preference of the editors/reviewers/referees, on selection and onward processing of manuscripts.
An author may request for withdrawal of his/her manuscript, within a week period (w.e.f. the date of our acknowledgement email of the receipt of a manuscript at our end).It is not appropriate for an author to ask for the withdrawal of a manuscript after the aforesaid period/ it is put in the review process of the Journal.
In cases where the journal facilitates provisioning of information on status of manuscripts, delays (if any) in the review/refereeing or publication of manuscripts, Journal is not obliged to reply or communicate to the authors on these subjects. Journal is not liable for any loss or consequences that might occur owing to use of the information/subject-matter embodied in the 'Journal.
Manuscript Submission Check List
Covering letter and Title page should be submitted as single file in First page file.
Abstract & Key words with main article should be submitted as article file.
Tables and Figures should be submitted as Images.
Scanned images of Undertaking and Copyright Transfer Agreement Form duly signed by all authors should be submitted as single file.
Editor In-Chief
Innovative Publication
H - 2 / 94, Bengali Colony, Mahaveer Enclave, Part - 1, New Delhi - 110045, India
Ph.: +91-11-25052216, Tele Fax: 11-25051061, Mob. : 08826373757, 08826859373
Email: editor@innovativepublication.com, rakesh.its@gmail.com Website: www.innovativepublication.com